
|Videos|August 28, 2021
Examining 10-year postop data on epi-off CXL for keratoconus, ectasia
Author(s)David Hutton, Alex Delaney-Gesing
Steven Greenstein, MD, reports on the 10-year postop data from an epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients.
Advertisement
Steven Greenstein, MD, of the Cornea and Laser Institute (Teaneck, NJ), reports on the 10-year postop data from an epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients who underwent laser refractive surgery.
Read the article:
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA update: Outlook Therapeutics receives CRL for resubmitted ONS-5010 BLA
2
FDA approvals in 2025: What changed and why it matters for ophthalmologists
3
Innovations in glaucoma poised for breakthrough in 2026 (and what might hold them back)
4
What changed in glaucoma care in 2025: Surgeon perspective
5












































